ArticleLife (Basel, Switzerland)2023

Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor Improves Leukocyte Energy Metabolism in Hereditary Hemorrhagic Telangiectasia.

Yves Schild et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.